Egg White Powder for High Blood Sugar and High Blood Pressure
Trial Summary
What is the purpose of this trial?
Bioactive peptides derived from food proteins show potential for improving human health. One of such promising peptides is namely IRW made from egg white hydrolysate and composed of three peptides. This is a feasibility study to assess the acute effect of IRW in egg white hydrolysate for the management of high sugar and blood pressure. Participants at high risk of type 2 diabetes (T2D) or having T2D will undergo 4 consecutive treatments of 1 day each (randomly), during which they will consume a standardized breakfast with a smoothie containing different protein powders. Each treatment will be separated by a minimum of 1-week. Participants in the healthy control group will undergo 1 treatment only (one day).
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those taking chronic anti-inflammatory drugs. Other anti-diabetic and lipid-lowering medications will be documented, so you may not need to stop them.
What data supports the effectiveness of the treatment IRW from Egg White Hydrolysate for high blood sugar and high blood pressure?
Is egg white powder safe for humans?
How is the egg white hydrolysate treatment different from other treatments for high blood pressure and high blood sugar?
This treatment uses a special protein from egg whites that is broken down into smaller pieces, which can help lower blood pressure by blocking a specific enzyme (angiotensin converting enzyme) that usually raises it. Unlike some medications, it is derived from a natural food source and has shown promising results in animal studies without causing allergic reactions.12348
Research Team
Jianping Wu, PhD
Principal Investigator
University of Alberta
Eligibility Criteria
This trial is for individuals at high risk of type 2 diabetes or those already diagnosed with it. They should be willing to consume a standardized breakfast with a smoothie containing different protein powders on four separate days, each one week apart. Healthy controls will participate in just one treatment.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 4 consecutive treatments of 1 day each, separated by a minimum of 1 week, consuming a standardized breakfast with a smoothie containing different protein powders.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- IRW from Egg White Hydrolysate
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor